Capabilities

Using the OPAL multipurpose reactor,, ANSTO can provide a diverse suite of radioisotopes for research and applications

Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals

The measurement and manipulation of radiation and radioactive materials within biological systems. Capabilities include access to a range of radioisotopes,   gamma/X-ray sources and a selection of X-ray beams, ion beams and neutron beams for irradiation. 

Expertise in the use of PET and SPECT imaging techniques to understand biological processes at the cellular and molecular level. The techniques ae also used to study disease processes and monitor the effects of new therapies

ANSTO provides a range of radiotracers for pre-clinical and clinical research using the OPAL multipurpose reactor. Users can access more than 300 known radiotracers. If a starting material is provided, new and non-commercial radiotracers can be produced.

The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.

Biosciences staff support research for radiopharmaceutical translation, radiation biology and radiotracer studies. New radiotracers can be fully characterised and assessed by a range of evaluation techniques, including in vitro and in vivo studies.

The use of radioisotopes, radiolabeled molecules and radioactive particles in conjunction with a range of quantitative imaging spectroscopy and radiation counting methods.